Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. scores highest on Torque (88) and lowest on Price (0). Its PosiPenta is 34.91 out of 100, weaker than most similar companies.
On the Penta Grid this week, Minerva Neurosciences, Inc. is Grid #675 of 837 in the Healthcare sector in United States, and Grid #3,308 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. | 34.91 | 0 | 41 | 16 | 88 | 30 |
| Voyager Therapeutics, Inc. | 38.74 | 43 | 39 | 19 | 44 | 49 |
| Humacyte, Inc. | 29.23 | 17 | 60 | 26 | 8 | 35 |
| Definitive Healthcare Corp. | 41.42 | 43 | 60 | 36 | 28 | 39 |
| Black Diamond Therapeutics, Inc. | 35.22 | 39 | 34 | 28 | 50 | 24 |
| Foghorn Therapeutics Inc. | 37.76 | 0 | 36 | 20 | 94 | 39 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.07 |
| P/B ratio | -0.53 |
EEarnings
| Trailing EPS | ₹-3421.10 |
| Forward EPS | ₹-39.78 |
NNitro
| Price | 222.58 |
| 52-week high | 1180.15 |
| 52-week low | 215.95 |
| Fall from 52-week high | 81.1% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | -0.12 |
| Market cap | ₹1,062 Cr |
| Insider holding | 3.26% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Minerva Neurosciences, Inc.'s PosiPenta score?
Minerva Neurosciences, Inc.'s PosiPenta is 34.91 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Minerva Neurosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Minerva Neurosciences, Inc. is Grid #675 of 837 in the Healthcare sector in United States, and Grid #3,308 of 4,000 in United States.
Which PosiPenta pillar is strongest for Minerva Neurosciences, Inc.?
Torque (durability), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Minerva Neurosciences, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Minerva Neurosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.66 points, from 32.25 to 34.91.
PositoAI is for research and education only and is not investment advice.